Understanding Side Effects of Migraine Medications: A Comprehensive Guide

Migraine medications can provide significant relief, but like all treatments, they may cause side effects that vary by medication type and individual patient factors. Understanding these potential effects helps patients and healthcare providers make informed treatment decisions and manage expectations during therapy.

Acute migraine treatments, including triptans and CGRP receptor antagonists, commonly cause mild to moderate side effects. Triptans may cause sensations of tightness, tingling, or warmth, while newer oral CGRP antagonists like ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) typically cause nausea or drowsiness in some patients. Injectable treatments such as lasmiditan (Reyvow) may cause dizziness or fatigue, requiring patients to avoid driving for several hours after administration.

Preventive migraine medications have distinct side effect profiles depending on their mechanism of action. CGRP monoclonal antibodies, including erenumab (Aimovig), fremanezumab (Ajovy), galcanezumab (Emgality), and eptinezumab (Vyepti), generally cause injection site reactions and may occasionally lead to constipation or muscle cramps. Oral preventive options like atogepant (Qulipta) may cause nausea, constipation, or fatigue in some patients.

Botulinum toxin injections for chronic migraine prevention, such as onabotulinumtoxinA (Botox), typically cause temporary injection site pain, muscle weakness, or headache. Most side effects from migraine medications are mild to moderate and often decrease over time as the body adjusts to treatment. Patients should discuss any concerning symptoms with their healthcare provider to determine the best management approach for their individual situation.